HER2 Expression in Breast Cancer Cells Is Downregulated Upon Active Targeting by Antibody-Engineered Multifunctional Nanoparticles in Mice | ACS Nano
Cancers | Free Full-Text | The Nitric Oxide Donor [Zn(PipNONO)Cl] Exhibits Antitumor Activity through Inhibition of Epithelial and Endothelial Mesenchymal Transitions
FNS - Bioblast
Maria BELLINI | Assistant Professor | MD, PhD, FEBS FACS | Sapienza University of Rome, Rome | la sapienza | Department of Surgical Sciences | Research profile
Vol. 06 | 3_2020
Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells. - Abstract - Europe PMC